Sanolla

Cardiopulmonary Diagnosis, Monitoring, and Screening

Health Tech & Life Sciences
Active
Seed Nesher Founded 2016
Total raised
$16.0M
Last: Seed 2022-04
Stage
Seed
Founded
2016
Headcount
21
HQ
Nesher
Sector
Health Tech & Life Sciences

About

Sanolla provides physicians and patients with smart diagnostic solutions designed to support the early assessment and monitoring of cardiopulmonary conditions such as congestive heart failure, pneumonia, asthma, chronic obstructive pulmonary disease, COVID-19, and more.

Based on AI-powered detection and analysis of previously inaccessible body infrasounds and other important vital signs (e.g., ECG, heart rate, oxygen level, body temperature, and respiratory cycle), Sanolla's products can provide immediate and accurate assessment, reducing unnecessary in-clinic visits, saving time and money, and lowering the associated risk of exposure to infections.

Funding history · 2 rounds · $16.0M total

2022-04
Seed $6.0M
2016-04
Seed Undisclosed

Sectors & technology

Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesMedical DevicesDiagnostics DevicesDigital HealthcareDigital Medical DiagnosticsPatient Remote Monitoring
Technologies
Platforms & InterfacesSoftwareArtificial IntelligenceDeep LearningMachine LearningSensing
Target customers
Healthcare & Life SciencesHealthcarePatientsProviders
Business model
B2B2CB2B

Highlights

1 PatentsVerified

Tags

telehealthmedical-devicesmachine-learningmedical-technologiesartificial-intelligencedata-analyticsdeep-learningmonitoringdiagnosticspulmonarynon-invasivesensorsdigital-healthcareearly-detection